Month: January 2024

Cooper™ Developer Platform Provides Power Efficient Solution for Industrial, AIoT, Intelligent Video Analytics and Edge AI Computing ApplicationsAmbarella’s Cooper™ Developer Platform Provides Power Efficient Solution for Industrial, AIoT, Intelligent Video Analytics and Edge AI Computing ApplicationsCooper offers seamless integration of software, hardware, state-of-the-art fine-tuned AI models, and services that provide universal support for Ambarella’s entire portfolio of AI systems-on-chip (SoCs).SANTA CLARA, Calif., Jan. 10, 2024 (GLOBE NEWSWIRE) — Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced during CES the leading-edge Cooper™ Developer Platform. Cooper offers seamless integration of software, hardware, state-of-the-art fine-tuned AI models, and services...

Banco Comercial Português, S.A. informs about potential issue of perpetual subordinated notesAttachment2023 01 10 Potencial emissão AT1 EN

Decision related to mandatory offer for all shares in BW Energy from BW Group Reference is made to the announcement made by BW Group Limited (the “Offeror”) on 13 December 2023 regarding the launch of a mandatory offer for all issued and outstanding common shares of BW Energy Limited (“BW Energy”) not already owned by the Offeror at a price of NOK 27 per share (the “Offer”), and the offer document for the Offer dated 13 December 2023. BW Offshore Limited (“BW Offshore” or the “Company”) owns 58,111,461 (22.52%) shares in BW Energy. Following the Offeror’s announcement on 30 November 2023 of its intention to launch the Offer, BW Offshore engaged Arctic Securities AS as its independent financial advisor to assist the Company in assessing the Offer. Based on careful assessment...

Millions of gifts are exchanged across Europe during the holiday season, but many are ultimately deemed unwanted and unnecessary. In fact, according to a survey of 5,000 Europeans commissioned by Adevinta, the leading classifieds group, two thirds (66%) of people state that they have received a brand-new gift that they’ve had no use for, or simply not liked.   Encouragingly, only 6% of these respondents say that they’ve thrown unwanted items away, and nearly a quarter (23%) have turned to online platforms to sell them on. France tops the re-commerce leaderboard with 27% of consumers having sold online compared to 20% of consumers in Spain and 19% of consumers in Italy.  The survey also found that among those that have received a brand-new gift they didn’t like:  28% have kept an unwanted gift, knowing it would never be useful ...

Marketing authorization issued in European Economic Area for Uzpruvo®, the first biosimilar to Stelara®, a biologic therapy within gastroenterology, dermatology, and rheumatology Authorization paves way for biosimilar competition in the approximately €2.5 billion (US$2.7 billion) EU ustekinumab market as soon as possible after expiry of intellectual-property rights in July 2024 Approval for the Uzpruvo biosimilar is based on comprehensive package comprising analytical, non-clinical and clinical similarity data, including the AVT04-GL-301 confirmatory comparative efficacy and safety clinical trial in patients with moderate to severe chronic plaque-type psoriasisPartners STADA and Alvotech today announced that the European Commission issued a marketing authorization for Uzpruvo® (AVT04), a biosimilar candidate to Stelara® (ustekinumab)....

Marketing authorization issued in European Economic Area for Uzpruvo®, the first biosimilar to Stelara®, a biologic therapy within gastroenterology, dermatology, and rheumatology Authorization paves way for biosimilar competition in the approximately €2.5 billion (US$2.7 billion) EU ustekinumab market as soon as possible after expiry of intellectual-property rights in July 2024 Approval for the Uzpruvo biosimilar is based on comprehensive package comprising analytical, non-clinical and clinical similarity data, including the AVT04-GL-301 confirmatory comparative efficacy and safety clinical trial in patients with moderate to severe chronic plaque-type psoriasisBAD VILBEL, Germany and REYKJAVIK, Iceland, Jan. 10, 2024 (GLOBE NEWSWIRE) — Partners STADA and Alvotech today announced that the European Commission issued a marketing...

HAMILTON, Ontario, Jan. 10, 2024 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it has expanded the contract previously signed in May 2023 with a large US health plan. The health plan operates Accountable Care Organizations (ACOs) and Health Maintenance Organizations (HMOs) in five States with over 3,000 doctors and more than 1,000,000 patients. The expansion is expected to add over 50,000 new patients to Reliq’s iUGO Care platform by the end of 2025 at an average revenue of $65 per patient per month. “We are very pleased that our client has asked to expand their deployments to include...

Press Release Reserved capital increase of €87,558,034.85released by set-off of receivable in accordance with the authorization given by the combined general meeting of December 19, 2023 Paris – January 10, 2024 – Vantiva (Euronext Paris: VANTI), today announced the completion of a reserved capital increase of €87,558,034.85 paid up by debt set-off. On January 9, 2024, the Chief Executive Officer, pursuant to the sub-delegation of authority granted to him by the Company’s Board of Directors on December 19, 2023, itself pursuant to the fourth resolution of the Company’s Combined General Meeting of December 19, 2023, duly acknowledged the completion of a share capital increase in the nominal amount of €1,347,046.69, through the creation and the issuance of 134,704,669 new ordinary shares with a par value of €0.01 each...

On 10 January 2024 the new wording of the Articles of Association of SC KN Energies (hereinafter – the Company) were registered within the Register of Legal Entities of the Republic of Lithuania following the amendment of the Company’s name. The change of legal name will have no effect on the Company’s employees, customers, and partners. The company’s obligations remain unchanged, there is no need to change contracts or agreements. The address of the Company’s registered office, address for correspondence, billing invoices, and other details also remain the same. KN will continue to use the brand which was updated in 2016.  With the change of the Company name, on January 10th, 2024, the ticker of SC „KN Energies“ securities on the Nasdaq Vilnius Stock Exchange changed from KNF1L to KNE1L. The securities ISIN code remains unchanged and...